The August 2010 merger between PoMedica and St. Luke’s Hospital made ProMedica the dominant hospital operator in the area, controlling more than 50 percent of the market for primary and secondary services. The Federal Trade Commission contested the transaction five months later. After a five-year court battle, ProMedica filed its application with the FTC to divest the hospital in May 2016. The two organizations officially became separate entities July 1, 2016, according to the article.
Mr. Wakeman said one of the biggest challenges the hospital has faced since becoming independent is footing the costs to pay for services ProMedica would have been responsible for under the merger agreement. Mr. Wakeman said the hospital aims to operate its own business platforms by March 31 and its own clinical platforms by November, according to the article.
But Mr. Wakeman said the split from ProMedica also has its benefits. Under the previous agreement, ProMedica dropped the hospital’s family medicine residency program. Following its disaffiliation with the health system, the hospital plans to create a new medical education training program, according to the article.
More articles on transactions and valuations:
This week’s 3 most-read transactions and valuations stories
Virginia state authorities extend review period for Wellmont-MSHA merger
29 recent hospital transactions and partnerships
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
